The presence of an EORTC/MSGERC risk factor was associated with an OR of 2.84 (95% CI; 0.7–11.63) in the sensitivity analysis, thereby showing the same direction of effect than in the primary study population (1:1 matching); however, this association did not reach statistical significance in the sensitivity analysis ( p = 0.146) (Table 2B ).
← all excerpts
Posaconazole for Prevention of COVID-19-Associated Pulmonary Aspergillosis in Mechanically Ventilated Patients: A European Multicentre Case-Control Study (POSACOVID).
1
0.1460
0.1460